Back to Trades
Duprey Lauren Rusckowski
Chief Transformation OfficerCIK 0001977746
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 4
- Buy transactions
- 0
- Sell transactions
- 2
- Companies
- 1
- Active
- 2026
Duprey Lauren Rusckowski, Chief Transformation Officer, has filed 4 SEC reports (2026), all concentrated in TAKEDA PHARMACEUTICAL CO LTD (TAK), totaling $1.5M in disclosed volume. Weighing $0 bought versus $1.5M sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
4 loaded
| Sep 15 | TAK TAKEDA PHARMACEUTICAL CO LTD | Duprey Lauren Rusckowski | Chief Transformation Officer | Sell | $640.3K |
| Aug 12 | TAK TAKEDA PHARMACEUTICAL CO LTD | Duprey Lauren Rusckowski | Chief Transformation Officer | Sell | $813.7K |
| Jul 6 | TAK TAKEDA PHARMACEUTICAL CO LTD | Duprey Lauren Rusckowski | Chief Transformation Officer | Grant | $0 |
| Apr 28 | TAK TAKEDA PHARMACEUTICAL CO LTD | Duprey Lauren Rusckowski | Chief Transformation Officer | Grant | $0 |
4 filings